Maristella Adami Selected Research

Disease Progression

5/2020

Treatments for COVID-19: emerging drugs against the coronavirus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maristella Adami Research Topics

Disease

4	Inflammation (Inflammations) 12/2018 - 06/2007
3	Edema (Dropsy) 12/2018 - 06/2007
2	Pruritus (Itching) 01/2021 - 12/2018
2	Otitis 12/2018 - 01/2012
1	Allergic Rhinitis 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Colitis 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Infections 05/2020
1	Disease Progression 05/2020
1	Irritant Dermatitis 12/2018
1	Carcinogenesis 01/2012
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2012
1	Neoplasms (Cancer) 01/2012
1	Hyperalgesia 06/2007
1	Bradycardia 01/2006

Drug/Important Bio-Agent (IBA)

4	Histamine H4 ReceptorsIBA 01/2021 - 06/2007
3	LigandsIBA 01/2021 - 01/2012
3	1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA 12/2018 - 06/2007
2	Croton OilIBA 12/2018 - 01/2012
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2012 - 06/2007
2	CarrageenanIBA 04/2008 - 06/2007
1	Pharmaceutical PreparationsIBA 05/2020
1	N4- (2,6- dichlorobenzyl)- 6- (4- methylpiperazin- 1- yl)pyrimidine- 2,4- diamineIBA 12/2018
1	2-aminopyrimidineIBA 12/2018
1	VUF 6002IBA 06/2007
1	Celecoxib (Celebrex)FDA Link 01/2006
1	SC 560IBA 01/2006
1	Dihydrotachysterol (AT 10)IBA 01/2006